Companies / Hawkins COMPANY FILINGS
Hawkins HWKN In fiscal 2026, ended March 29, 2026, Hawkins formulated, manufactured, distributed and blended water-treatment and specialty-ingredient products through its Water Treatment, Food and Health Sciences, and Industrial Solutions segments.
Business description: FY2026 CIK 0000046250 Source: SEC EDGAR
Overview 10-K summary Balance sheet Original filings
Annual reports 5
Report coverage 2022–2026
Financial statement focus Balance sheet READ THE FILING
Annual report insights AI summary AI-generated summaries of the cited 10-K filings. For informational purposes only; not personalized investment advice.
Choose a fiscal year FY2026 Fiscal 2026 sales increased 11% from fiscal 2025 to US$1,083.7 million, while diluted earnings per share—profit per share allowing for potential additional shares—decreased 3% to US$3.91.
Source: 2026 Hawkins acquired substantially all WaterSurplus assets and assumed certain liabilities in April 2025, paying approximately US$149.9 million at closing. An additional performance-based payment (an earnout) of up to US$53.7 million depends on cumulative gross profit, sales less product costs, over the first five years. This is a conditional maximum, not an additional amount already paid.
Source: 2026 View full 10-K summary 2026 Hide full 10-K summary 2026 Signals describe observations in the selected filing, not forecasts or investment ratings. Risk disclosures do not establish that a loss occurred.
Positive signals Operating cash Operating cash flow reached US$144.3 million in fiscal 2026, compared with US$111.1 million in fiscal 2025. Management primarily attributed the increase to favorable year-over-year changes in inventories and trade receivables, amounts customers owed.
Source: 2026 Negative signals Pricing pressure Food and Health Sciences gross profit—sales less product costs—decreased 6% to $67.3 million in fiscal 2026 from $71.9 million in fiscal 2025. Management attributed the decline to lower selling prices, primarily resulting from competitive pricing pressure.
Source: 2026 Acquisition costs WaterSurplus contributed a $3.9 million operating loss to fiscal 2026 consolidated results. Company-wide interest expense rose to $13.5 million from $5.4 million in fiscal 2025; management attributed the increase to higher borrowings, primarily to fund current-year acquisitions.
Source: 2026 Remediation No expenses were charged in fiscal 2026 against the US$7.7 million estimated soil-cleanup obligation recorded in fiscal 2024 for the Rosemount facility. A recorded liability is an accounting estimate of an obligation, rather than a cash fund. Separately, Hawkins said additional cleanup expenses were reasonably possible if new information or conditions emerged, but it could not reasonably estimate their amount or range. The absence of expenses charged against that liability does not establish that cleanup was complete.
Source: 2026 Business in fiscal 2026 In fiscal 2026, ended March 29, 2026, Hawkins formulated, manufactured, distributed and blended water-treatment and specialty-ingredient products through its Water Treatment, Food and Health Sciences, and Industrial Solutions segments.
Source: 2026
5-year changes FY2022–FY2026 These changes use selected original filing passages and nearby context from the stated five fiscal years. They are not an exhaustive review of all five reports and exclude later-year filings.
Business groups In fiscal 2022, Hawkins reported three business groups: Industrial, Water Treatment, and Health and Nutrition. Beginning in the first quarter of fiscal 2026, it realigned reporting into Water Treatment, Food and Health Sciences, and Industrial Solutions. The fiscal 2026 report also recast fiscal 2024 and fiscal 2025 segment information, meaning it presented those earlier years using the new group definitions.
Source: 2022 , 2026 Borrowings Borrowings outstanding under Hawkins' revolving loan facility—a credit line that can be borrowed, repaid and reused— fell from $126.0 million on April 3, 2022, to $112.0 million on April 2, 2023, and $99.0 million on March 31, 2024. They then rose to $149 million on March 30, 2025, and $244 million on March 29, 2026. These are amounts borrowed at each fiscal year-end, not the facility's total borrowing limit.
Source: 2022 , 2023 , 2024 , 2025 , 2026 Operating cash Cash generated by operating activities was $42.8 million in fiscal 2022 and $144.3 million in fiscal 2026. In fiscal 2022, management said inventory increased because of higher raw-material costs and a deliberate buildup in response to customer demand and supply-chain issues. In fiscal 2026, it attributed the operating-cash increase from fiscal 2025 primarily to favorable changes in inventories and trade receivables, or amounts customers owed.
Source: 2022 , 2026 Request a correction FINANCIAL STATEMENTS
Balance sheet A snapshot of what Hawkins owns and owes at a point in time.
The original comes first. Read the company’s balance sheet in the original annual reports below.
Browse original filings
Assets What the company owns
Liabilities What the company owes
Equity Assets less liabilities See the original statement for its reporting period, currency, and unit.
SOURCE LIBRARY
Annual reports & SEC 10-K filings SEC EDGAR 5 reports in this collection
Report yearAll years 2026 2025 2024 2023 2022 Dates describe the filing metadata. Figures and reporting periods should be checked against the original statement. SEC links open in a new tab.
About this collection This is a selected archive of up to ten annual reports per company. It does not include every filing or update automatically. Visit the original SEC filings for the full context.
Our approach to the data 